Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: Preliminary experience

Keyphrases

• High Risk 100%
• Angioplasty 100%
• Abciximab 100%
• Vertebrobasilar 100%
• Bleeding 37%
• Clinical High Risk 25%
• Heparin 25%
• Intra-procedural 25%
• Basilar Artery 25%
• Hemoglobin Decrease 25%
• Vertebral Artery 12%
• Neurological Events 12%
• Thrombocytopenia 12%
• Hospitalization 12%
• Coronary Intervention 12%
• Endovascular Treatment 12%
• Recanalization 12%
• Complex Lesions 12%
• Bolus 12%
• Intra-arterial 12%
• Major Bleeding 12%
• Internal Carotid Artery 12%
• Neurologist 12%
• Stent Placement 12%
• Complete Occlusion 12%
• Ischemic Symptoms 12%
• Platelet Glycoproteins 12%
• Concomitant Administration 12%
• Minor Bleeding 12%
• Lesion Morphology 12%
• Right Vertebral Artery 12%
• Post-procedural Bleeding 12%
• Vertebral Artery Angioplasty 12%
• 2-stent 12%
• Ischemic Events 12%
• Neurointerventional Procedures 12%
• Thrombolytic Agents 12%
• Transient Neurological Deficits 12%
• Extensive Lesion 12%
• New Neurologic Deficit 12%
• Receptor Inhibitors 12%
• Intravenous Heparin 12%

Medicine and Dentistry

• Angioplasty 100%
• Abciximab 100%
• Bleeding 62%
• Infusion 37%
• Heparin 37%
• Vertebral Artery 37%
• Low Drug Dose 25%
• Thrombolytic Drug 25%
• Basilar Artery 25%
• Hemoglobins 25%
• Receptor 12%
• Recanalization 12%
• Thromboembolism 12%
• Internal Carotid Artery 12%
• Stent Placement 12%
• Thrombocytopenia 12%
• Platelet Glycoprotein 12%